AzTrials
AzTrials

PerfectionismNCT04500457

Exposure-Based Treatment for Perfectionism

A study testing Exposure-based Treatment for Perfectionism (ETP) in people with Perfectionism, run by Florida State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is examining the efficacy of a computerized, exposure-based, intervention for perfectionism. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Perfectionism
What is being tested?
Exposure-based Treatment for Perfectionism (ETP)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
76 participants
Where
1 siteUnited States
Study dates
3 Oct 2019to 26 Feb 2021
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Score of at least 29 on the Frost Multidimensional Perfectionism Scale- Concern over Mistakes subscale

Who cannot join

  • Current moderate or severe substance use disorder, psychotic disorder, or bipolar disorder
  • Current suicidal ideation (imminent risk)
  • Currently participating in psychotherapy
  • Any changes to psychotropic medications in the past four weeks

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Florida State University, Department of Psychology

    Tallahassee, Florida, 32306

Other trials in United States

About this study

Official title: A Preliminary Evaluation of an Exposure-Based Treatment for Perfectionism

This study is examining the efficacy of a computerized, exposure-based, intervention for perfectionism.

Read the detailed description

The primary aim of this study is to evaluate the effects of a two-week computerized exposure-based treatment for perfectionism (ETP). Individuals with elevated perfectionism will be randomly assigned to ETP or a waitlist (WL) control condition. ETP will consist of three tasks in which they will repeatedly make mistakes, repeated for five sessions over a two-week period (one session every 3 days).

Conditions
Perfectionism
Being tested
Exposure-based Treatment for Perfectionism (ETP)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exposure-based Treatment for Perfectionism (ETP)Behavioural

    Three tasks focused on exposures are completed. Each treatment session is approximately twenty minutes.

Study groups in NCT04500457
Study groupRoleWhat they receive
InterventionExperimentalThis arm consists of a 2-week computerized, exposure-based intervention. Treatment sessions are completed every 3 days at home (5 treatment sessions total).
Receives: Behavioral: Exposure-based Treatment for Perfectionism (ETP)
Wait-List ControlNo interventionParticipants in this condition will not receive treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Frost Multidimensional Perfectionism Scale (FMPS)- Concern Over Mistakes Subscale

    Self-report questionnaire examining levels of perfectionism. The concern over mistakes sub-scale of the Frost Multidimensional Perfectionism Scale includes 9 items with scores on the sub-scale ranging from 9 to 45 (higher scores signify higher levels of concern over mistakes). The concern over mistakes sub-scale includes the following items from the Frost Multidimensional Perfectionism Scale: 9, 10, 13, 14, 18, 21, 23, 25, 24. Item scores are summed for a total sub-scale score.

    Measured: Levels of perfectionism from baseline to post treatment (2 weeks)

Secondary outcomes (5)
  1. Center for Epidemiological Studies Depression Scale (CES-D)

    Self-report measure used to assess depressive symptoms. Total scores range from 0 to 60 with higher scores indicating a higher level of depressive symptoms.

    Measured: Depression symptoms from baseline to post treatment (2 weeks)

  2. State-Trait Inventory for Cognitive and Somatic Anxiety-Trait Version (STICSA-T)

    Self-report measure used to assess overall anxiety symptoms. Scores range from 21 to 84 with higher scores indicating higher levels of overall anxiety.

    Measured: Anxiety symptoms from baseline to post treatment (2 weeks)

  3. Social Phobia Inventory (SPIN)

    Self-report scale that measures Social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.

    Measured: Social anxiety symptoms from baseline to post treatment (2 weeks)

  4. Eating Attitudes Test (EAT-26)

    Self-report scale that measures eating disorder symptoms. Scores range from 0 to 78 with higher scores indicating higher levels of eating disorder symptoms.

    Measured: Eating disorder symptoms from baseline to post treatment (2 weeks)

  5. Obsessive-Compulsive Inventory- Revised (OCI-R)

    Self-report scale that measures obsessive-compulsiveness. Scores range from 0 to 72 with higher scores indicating higher levels of obsessive-compulsiveness.

    Measured: Obsessive-compulsiveness from baseline to post treatment (2 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2020
  2. Study start3 Oct 2019
  3. Primary completion26 Feb 2021
  4. Study completion26 Feb 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
76 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04500457
Sponsor's protocol ID
HSC2019.27351
Status last verified
Jul 2023
First submitted
3 Aug 2020
Last updated
27 Jul 2023
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Exposure-based Treatment for Perfectionism (ETP) in people with Perfectionism, run by Florida State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 27 Jul 2023). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Frost Multidimensional Perfectionism Scale (FMPS)- Concern Over Mistakes Subscale (time frame: Levels of perfectionism from baseline to post treatment (2 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2023; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in